BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37963801)

  • 1. CRISPR/Cas13-assisted carbapenem-resistant Klebsiella pneumoniae detection.
    Cao Y; Tian Y; Huang J; Xu L; Fan Z; Pan Z; Chen S; Gao Y; Wei L; Zheng S; Zhang X; Yu Y; Ren F
    J Microbiol Immunol Infect; 2024 Feb; 57(1):118-127. PubMed ID: 37963801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbapenem antibiotic stress increases bla
    Chen H; Li N; Wang F; Wang L; Liang W
    J Clin Lab Anal; 2022 Jul; 36(7):e24519. PubMed ID: 35718993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic resistance and virulence characteristics of four carbapenem-resistant Klebsiella pneumoniae strains coharbouring bla
    Bai J; Liu Y; Kang J; Song Y; Yin D; Wang S; Guo Q; Wang J; Duan J
    Microb Pathog; 2023 Feb; 175():105969. PubMed ID: 36610697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of novel sequence type of carbapenem-resistant New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in the neonatal intensive care unit of an Indian hospital.
    Ahmad N; Ali SM; Khan AU
    Int J Antimicrob Agents; 2019 Apr; 53(4):525-529. PubMed ID: 30578964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role of outer membrane vesicles in antibiotic resistance in carbapenem-resistant Klebsiella pneumoniae.
    Yao L; Wei B; Wang Y; Xu B; Yang M; Chen X; Chen F
    Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):95. PubMed ID: 37919721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of Carbapenemase Nordmann-Poirel, Modified Carbapenem Inactivation, and EDTA Carbapenem Inactivation Methods for Detecting Carbapenem-Resistant
    Sarva K; Marimuthu Ragavan R; Tadi LJ; Raja S; Narasingam A
    Microb Drug Resist; 2023 Nov; 29(11):504-509. PubMed ID: 37729073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
    Zornic S; Petrovic I; Lukovic B
    Acta Microbiol Immunol Hung; 2023 Sep; 70(3):187-192. PubMed ID: 37535440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characteristics and virulence factors of carbapenem-resistant Klebsiella pneumoniae among pediatric patients in Shanghai, China.
    Yin L; Yan G; Lu L; He L; Wu N; Cao Y; Lu G; Zhai X; Wang C
    Infect Genet Evol; 2023 Aug; 112():105451. PubMed ID: 37230160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance Phenotype and Molecular Epidemiology of Carbapenem-Resistant
    Zhang WX; Chen HY; Chen C; Chen JH; Wan FS; Li LX; Chen M; Zhang J
    Microb Drug Resist; 2021 Oct; 27(10):1312-1318. PubMed ID: 34297609
    [No Abstract]   [Full Text] [Related]  

  • 11. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of CRISPR-Cas Systems in Clinical Carbapenem-Resistant
    Liao W; Liu Y; Chen C; Li J; Du F; Long D; Zhang W
    Microb Drug Resist; 2020 Jun; 26(6):630-636. PubMed ID: 31834846
    [No Abstract]   [Full Text] [Related]  

  • 13. Virulence, antimicrobial resistance, and molecular characteristics of carbapenem-resistant Klebsiella pneumoniae in a hospital in Shijiazhuang City from China.
    Guo Y; Liu F; Zhang Y; Wang X; Gao W; Xu B; Li Y; Song N
    Int Microbiol; 2023 Nov; 26(4):1073-1085. PubMed ID: 37097488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic analysis of the emerging carbapenem-resistant Klebsiella pneumoniae sequence type 11 harbouring Klebsiella pneumoniae carbapenemase (KPC) in Oman.
    Balushi MA; Kumar R; Al-Rashdi A; Ratna A; Al-Jabri A; Al-Shekaili N; Rani R; Sumri SA; Al-Ghabshi L; Al-Abri S; Al-Jardani A
    J Infect Public Health; 2022 Oct; 15(10):1089-1096. PubMed ID: 36116408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
    Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
    Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Epidemiology, Microbial Virulence, and Resistance of Carbapenem-Resistant
    Peng C; Feng DH; Zhan Y; Wang Q; Chen DQ; Xu Z; Yang L
    Microb Drug Resist; 2022 Jun; 28(6):698-709. PubMed ID: 35639427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae isolates in central Iran.
    Abbasi E; Ghaznavi-Rad E
    BMC Microbiol; 2023 Apr; 23(1):98. PubMed ID: 37038144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of KPC-2 and NDM-5-coproducing hypervirulent carbapenem-resistant
    Zhou Y; Wu X; Wu C; Zhou P; Yang Y; Wang B; Xu Y; Zhao H; Guo Y; Yu J; Yu F
    mSphere; 2024 Jan; 9(1):e0061223. PubMed ID: 38193656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Surveillance of Carbapenem-Resistant Klebsiella pneumoniae from a Major Public Health Hospital in Singapore.
    Teo JQ; Tang CY; Tan SH; Chang HY; Ong SM; Lee SJ; Koh TH; Sim JH; Kwa AL; Ong RT
    Microbiol Spectr; 2022 Oct; 10(5):e0095722. PubMed ID: 36066252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct prediction of carbapenem-resistant, carbapenemase-producing, and colistin-resistant Klebsiella pneumoniae isolates from routine MALDI-TOF mass spectra using machine learning and outcome evaluation.
    Yu J; Lin YT; Chen WC; Tseng KH; Lin HH; Tien N; Cho CF; Huang JY; Liang SJ; Ho LC; Hsieh YW; Hsu KC; Ho MW; Hsueh PR; Cho DY
    Int J Antimicrob Agents; 2023 Jun; 61(6):106799. PubMed ID: 37004755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.